Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Medtronic
Colorcon
Dow
Healthtrust
UBS
Harvard Business School
Queensland Health
Merck

Generated: December 12, 2018

DrugPatentWatch Database Preview

Nitazoxanide - Generic Drug Details

« Back to Dashboard

What are the generic sources for nitazoxanide and what is the scope of nitazoxanide patent protection?

Nitazoxanide is the generic ingredient in one branded drug marketed by Romark and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for nitazoxanide. One supplier is listed for this compound.

Pharmacology for nitazoxanide
Drug ClassAntiprotozoal
Synonyms for nitazoxanide
(2-((5-Nitro-2-thiazolyl)carbamoyl)phenyl)acetat
[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate
[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] ethanoate
[2-[(5-nitrothiazol-2-yl)carbamoyl]phenyl] acetate
2-?(ACETYLOXY)-?N-?(5-?NITRO-?2-?THIAZOLYL)-?BENZAMIDE
2-((5-nitrothiazol-2-yl)carbamoyl)phenyl acetate
2-(acetolyloxy)-N-(5-nitro-2-thiazolyl) benzamide
2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide
2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide
2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate
2-[N-(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate
2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide
4CH-006389
55981-09-4
981N094
A830877
AB0010620
AB00639988_10
AB00639988_11
AB00639988-07
AB00639988-09
AB2000173
AC-1302
AC1L26A1
AC1Q5NVY
acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester
Adrovet
AJ-47500
AK-26130
AKOS015915393
Alinia
Alinia (TN)
Alinia(TM)
AN-15061
Annita (TN)
API0015832
AX8040854
AZT + Nitazoxanide
azt+ nitazoxanide
BC222307
BDBM50075050
Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-
BG0652
BR-26130
BRN 1225475
C-23836
C12H9N3O5S
CAS-55981-09-4
CC-32885
CCG-35851
CHEBI:94807
CHEMBL1401
CN0040
Colufase
CPD000466367
Cryptaz
CS-2164
D02486
D08EBN
Daxon
Daxon (TN)
Daxon, Dexidex, Kidonax, Pacovanton, Paramix, Nitax, Zox, Nitazoxanide
DB00507
Dexidex
Dexidex (TN)
DR001275
DSSTox_CID_13757
DSSTox_GSID_33757
DSSTox_RID_79095
DTXSID5033757
EINECS 259-931-8
EN300-220095
FT-0082459
FT-0601547
HE115651
HE353061
Heliton
HMS2051L04
HMS3393L04
HMS3655M11
HY-B0217
I14-6011
J10428
Kidonax
Kidonax (TN)
KS-00000VRX
KS-1160
LS-144176
MCULE-8701444531
MFCD00416599
MLS000759492
MLS001424074
MLS006010127
MMV688991
MolPort-002-042-244
N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester)
N-(5-Nitrothiazol-2-yl)salicylamide acetate ester
N1031
NC00246
NCGC00090774-01
NCGC00090774-02
NCGC00090774-03
NCGC00090774-04
NCGC00090774-05
NCGC00258778-01
NCI60_034935
NCIMech_000843
Nitax
Nitax (TN)
Nitaxozanid
Nitaxozanide
nitazode
Nitazox
Nitazox (TN)
Nitazoxamide
Nitazoxanid
Nitazoxanida
Nitazoxanida [INN-Spanish]
Nitazoxanide (Alinia, Annita)
Nitazoxanide (USAN/INN)
Nitazoxanide [USAN:INN:BAN]
Nitazoxanide [USAN:INN]
Nitazoxanide, >=98% (HPLC)
Nitazoxanide, United States Pharmacopeia (USP) Reference Standard
Nitazoxanidum
Nitazoxanidum [INN-Latin]
nizonide
Nodik
NSC 697855
NSC-697855
NSC-760057
NSC697855
NSC760057
NTZ
NTZ; 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide
o-(N-(5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate
Omniparax
Oprea1_263587
Pacovanton
Pacovanton (TN)
Paramix
Paramix (TN)
PH 5776
PH-5776
Pharmakon1600-01503843
Phavic-1
Q-201475
S-3645
Salicylamide, N-(5-nitro-2-thiazolyl)- acetate (ester)
Salicylamide, N-(5-nitro-2-thiazolyl)-, acetate (ester)
Salicylamide, N-(5-nitro-2-thiazolyl)-acetate (ester)
SAM001246708
SBB068315
SCHEMBL40981
SMR000466367
SOA12P041N
ST2409239
ST51059722
STK395664
Taenitaz
Tox21_111018
Tox21_111018_1
Tox21_201226
Toza
UNII-SOA12P041N
Z1514087129
ZINC3956788
Zox
Zox (TN)

US Patents and Regulatory Information for nitazoxanide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for nitazoxanide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Sign Up ➤ Sign Up
Romark ALINIA nitazoxanide TABLET;ORAL 021497-001 Jul 21, 2004 ➤ Sign Up ➤ Sign Up
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Sign Up ➤ Sign Up
Romark ALINIA nitazoxanide FOR SUSPENSION;ORAL 021498-001 Nov 22, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
QuintilesIMS
Teva
Johnson and Johnson
Colorcon
McKinsey
Deloitte
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.